tetano
Editor, Senior Moderator
Vaccine. 2017 Aug 3. pii: S0264-410X(17)31019-8. doi: 10.1016/j.vaccine.2017.07.093. [Epub ahead of print]
[h=1]Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virus.[/h] Suzuki T[SUP]1[/SUP], Ainai A[SUP]2[/SUP], Hasegawa H[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Mucosal tissues are major targets for pathogens. The secretions covering mucosal surfaces contain several types of molecules that protect the host from infection. Among these, mucosal immunoglobulins, including secretory IgA (S-IgA) antibodies, are the major contributor to pathogen-specific immune responses. IgA is the primary antibody class found in many external secretions and has unique structural and functional features not observed in other antibody classes. Recently, extensive efforts have been made to develop novel vaccines that induce immunity via the mucosal route. S-IgA is a key molecule that underpins the mechanism of action of these mucosal vaccines. Thus, precise characterization of S-IgA induced by mucosal vaccines is important, if the latter are to be used successfully in a clinical setting. Intensive studies identified the fundamental characteristics of S-IgA, which was first discovered almost half a century ago. However, S-IgA itself has not gained much attention of late, despite its importance to mucosal immunity; therefore, some important questions remain. This review summarizes the current understanding of the molecular characteristics of S-IgA and its role in intranasal mucosal vaccines against influenza virus infection.
Copyright ? 2017. Published by Elsevier Ltd.
[h=4]KEYWORDS:[/h] Influenza; Influenza virus; Intranasal inactivated influenza vaccine; Mucosal immunoglobulin; Mucosal vaccine; Secretory IgA
PMID: 28780981 DOI: 10.1016/j.vaccine.2017.07.093
[h=1]Functional and structural characteristics of secretory IgA antibodies elicited by mucosal vaccines against influenza virus.[/h] Suzuki T[SUP]1[/SUP], Ainai A[SUP]2[/SUP], Hasegawa H[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Mucosal tissues are major targets for pathogens. The secretions covering mucosal surfaces contain several types of molecules that protect the host from infection. Among these, mucosal immunoglobulins, including secretory IgA (S-IgA) antibodies, are the major contributor to pathogen-specific immune responses. IgA is the primary antibody class found in many external secretions and has unique structural and functional features not observed in other antibody classes. Recently, extensive efforts have been made to develop novel vaccines that induce immunity via the mucosal route. S-IgA is a key molecule that underpins the mechanism of action of these mucosal vaccines. Thus, precise characterization of S-IgA induced by mucosal vaccines is important, if the latter are to be used successfully in a clinical setting. Intensive studies identified the fundamental characteristics of S-IgA, which was first discovered almost half a century ago. However, S-IgA itself has not gained much attention of late, despite its importance to mucosal immunity; therefore, some important questions remain. This review summarizes the current understanding of the molecular characteristics of S-IgA and its role in intranasal mucosal vaccines against influenza virus infection.
Copyright ? 2017. Published by Elsevier Ltd.
[h=4]KEYWORDS:[/h] Influenza; Influenza virus; Intranasal inactivated influenza vaccine; Mucosal immunoglobulin; Mucosal vaccine; Secretory IgA
PMID: 28780981 DOI: 10.1016/j.vaccine.2017.07.093